<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Decision to start hydroxyurea in SCD</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Decision to start hydroxyurea in SCD</h1>
<div class="graphic"><div class="figure"><div class="ttl">Decision to start hydroxyurea in SCD</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Baseline testing is required before starting hydroxyurea, and monitoring (eg, complete blood count, reticulocyte count, percent HbF, creatinine) continues throughout administration, with more frequent monitoring during dose escalation. Patients with SCD should receive comprehensive care from a clinician with experience managing hemoglobinopathies. The primary clinician may be aware of other aspects of the patient's clinical condition or the patient's or parents' values and preferences that may impact decision-making. Refer to UpToDate topics on SCD management and the use of hydroxyurea in SCD for further information.</div><div class="graphic_footnotes">SCD: sickle cell disease, which includes all homozygous (HbSS) or compound heterozygous genotypes; HU: hydroxyurea.<br/>* Symptomatic disease generally refers to more than one painful episode or episode of dactylitis requiring hospitalization in a one-year period or more than one episode of acute chest syndrome in a two-year period. Different criteria may be needed for some individuals, such as a single clinically significant episode of dactylitis, hepatic sequestration, or splenic sequestration in an infant; chronic pain; severe, symptomatic anemia due to SCD in an adult; or repeated vaso-occlusive events at lower frequency than that used in trials for any age group.<br/>¶ Genotype is usually inferred from hemoglobin analysis rather than DNA testing. Common genotypes are shown. Individuals with HbSS or sickle β<sup>0</sup> thalassemia are most likely to develop symptomatic disease if untreated. Those with HbSC or HbS/β<sup>+</sup> thalassemia are least likely to develop severe disease. Decisions for other genotypes are individualized.</div><div id="graphicVersion">Graphic 112513 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
